Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 6.82
(0.74%)
CNY 6.82
(0.74%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 101.11 Million CNY | -37.68% |
| 2022 | 183.28 Million CNY | 62.37% |
| 2021 | 120.47 Million CNY | 74.21% |
| 2020 | 59.72 Million CNY | -18.99% |
| 2019 | 93.14 Million CNY | 26.08% |
| 2018 | 70.87 Million CNY | -59.8% |
| 2017 | 116.71 Million CNY | 34.42% |
| 2016 | 134.3 Million CNY | -7.11% |
| 2015 | 138.31 Million CNY | 8.86% |
| 2014 | 126.7 Million CNY | -23.88% |
| 2013 | 164.63 Million CNY | 7.67% |
| 2012 | 154.2 Million CNY | 25.74% |
| 2011 | 123.22 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -6.33 Million CNY | 509.7% |
| 2024 Q3 | -15.96 Million CNY | -153.63% |
| 2024 Q2 | 26.49 Million CNY | 508.51% |
| 2023 Q1 | 11.78 Million CNY | -87.44% |
| 2023 FY | - CNY | -37.68% |
| 2023 Q2 | 43.05 Million CNY | 265.3% |
| 2023 Q4 | 802.63 Thousand CNY | 114.19% |
| 2023 Q3 | -5.65 Million CNY | -113.14% |
| 2022 Q3 | 21 Million CNY | -2.59% |
| 2022 FY | - CNY | 62.37% |
| 2022 Q4 | 93.87 Million CNY | 347.0% |
| 2022 Q1 | 16.13 Million CNY | -31.72% |
| 2022 Q2 | 21.55 Million CNY | 33.64% |
| 2021 FY | - CNY | 74.21% |
| 2021 Q1 | 17.71 Million CNY | 108.37% |
| 2021 Q2 | 15.25 Million CNY | -13.89% |
| 2021 Q3 | 8.97 Million CNY | -41.17% |
| 2021 Q4 | 23.62 Million CNY | 163.26% |
| 2020 Q4 | 8.5 Million CNY | 56.55% |
| 2020 Q1 | 6.51 Million CNY | 51.25% |
| 2020 Q3 | 5.43 Million CNY | 168.07% |
| 2020 Q2 | -7.97 Million CNY | -222.51% |
| 2020 FY | - CNY | -18.99% |
| 2019 Q1 | 3.53 Million CNY | 110.38% |
| 2019 FY | - CNY | 26.08% |
| 2019 Q2 | 12.57 Million CNY | 256.17% |
| 2019 Q4 | 4.3 Million CNY | -53.09% |
| 2019 Q3 | 9.17 Million CNY | -27.03% |
| 2018 Q1 | 15.6 Million CNY | -70.17% |
| 2018 FY | - CNY | -59.8% |
| 2018 Q4 | -34 Million CNY | -314.5% |
| 2018 Q3 | 15.85 Million CNY | -11.72% |
| 2018 Q2 | 17.95 Million CNY | 15.09% |
| 2017 Q1 | 21.29 Million CNY | -0.15% |
| 2017 FY | - CNY | 34.42% |
| 2017 Q4 | 52.29 Million CNY | 102.0% |
| 2017 Q3 | 25.88 Million CNY | -29.22% |
| 2017 Q2 | 36.57 Million CNY | 71.74% |
| 2016 Q2 | 16.54 Million CNY | -45.82% |
| 2016 FY | - CNY | -7.11% |
| 2016 Q3 | 14.12 Million CNY | -14.63% |
| 2016 Q1 | 30.53 Million CNY | 18.42% |
| 2016 Q4 | 21.32 Million CNY | 51.01% |
| 2015 Q1 | 33.74 Million CNY | 284.89% |
| 2015 FY | - CNY | 8.86% |
| 2015 Q4 | 25.78 Million CNY | 1.31% |
| 2015 Q3 | 25.45 Million CNY | 10.34% |
| 2015 Q2 | 23.06 Million CNY | -31.64% |
| 2014 FY | - CNY | -23.88% |
| 2014 Q3 | 29.23 Million CNY | 24.3% |
| 2014 Q1 | 36.93 Million CNY | 0.0% |
| 2014 Q2 | 23.52 Million CNY | -36.31% |
| 2014 Q4 | 8.76 Million CNY | -70.01% |
| 2013 FY | - CNY | 7.67% |
| 2012 FY | - CNY | 25.74% |
| 2011 FY | - CNY | 0.0% |